This trial is a prospective and multicenter clinical trial. 189 subjects are expected to be recruited in 20 research centers in China.~All subjects with coronary calcified lesions participating in this clinical study must have only one lesion length of no more than 40 mm and located in an coronary artery with a diameter of ≥ 2.00 mm but ≤ 4.00 mm.~All subjects receive clinical follow-up during hospitalization, 30 days and 6 months after surgery.
This is a prospective and multicenter clinical investigation aiming to evaluate the safety and effectiveness of coronary intravascular lithotripsy system for the treatment of patients with coronary calcification.